DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
Recruiting · NCT07059650 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-04-01 | NCT07059650 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dizal Pharmaceuticals | 20 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Cancer Hospital | Hefei | China | 9 |
| Guangdong Provincial People's Hospital | Guangzhou | China | 37 |
| Henan Cancer Hospital | Zhengzhou | China | 60 |
| Hunan Cancer Hospital | Changsha | China | 47 |
| Linyi Cancer Hospital | Linyi | China | 19 |
| Peking University Third Hospital | Beijing | China | 71 |
| Shanxi Cancer Hospital | Taiyuan | China | 17 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi'an | China | 39 |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou | China | 18 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 37 |
| West China Hospital of Sichuan University | Chengdu | China | 30 |
| Zhujiang Hospital of Southern Medical University | Guangzhou | China | 7 |